CLINICAL CHARACTERISTICS OF BREAST CANCER WITH STEROID RECEPTORS EXPRESSION AND HER2 AMPLIFICATION
Since the middle of the previous century the heterogeneity of breast cancer became absolutely evident. This assumption was historically based on differences in clinical behavior and sensitivity to therapy. Treatment approach nowadays is based primarily on clinical and morphological prognostic...
Saved in:
| Main Authors: | F. V. Moiseenko, V. F. Semiglazov, T. Yu. Semiglazova, A. A. Bogdanov, I. E. Eliseev, A. O. Ivantsov, N. А. Knyasev, I. N. Terterov, А. A. Kornev, M. V. Dubina |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Bashkir State Medical University
2017-02-01
|
| Series: | Креативная хирургия и онкология |
| Subjects: | |
| Online Access: | https://www.surgonco.ru/jour/article/view/178 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Current approaches to the treatment of HER2‑positive breast cancer with brain metastases
by: T. Yu. Semiglazova, et al.
Published: (2021-06-01) -
Comparative evaluation of the prognostic significance of molecular tumor markers (estrogen and progesterone receptors, HER-2/neu) and the Nottingham prognostic index in breast cancer
by: V. Sekhri, et al.
Published: (2024-02-01) -
STUDY OF THE EFFECT OF LOMUSTIN ON HER2-POSITIVE BREAST CANCER IN FVB/N HER-2 TRANSGENIC MICE
by: A. N. Stukov, et al.
Published: (2019-11-01) -
Improving treatment outcomes for patients with HER2‑positive breast cancer using neoadjuvant double HER2 blockade
by: V. F. Semiglazov, et al.
Published: (2024-11-01) -
Trends in breast cancer among elderly women: Development in estrogen and HER2 subtypes in the last ten years
by: Frederik K. Palshof, et al.
Published: (2025-02-01)